Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection

por Gui, Honglian, Wang, Weijing, Li, Qing, Li, Ziqiang, Lu, Jie, Xie, Qing
Publicado 2021

Pseudogene UBE2MP1 derived transcript enhances in vitro cell proliferation and apoptosis resistance of hepatocellular carcinoma cells through miR-145-5p/RGS3 axis

por Hao, Fengjie, Wang, Nan, Gui, Honglian, Zhang, Yifan, Wu, Zhiyuan, Wang, Junqing
Publicado 2022

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy

por Gui, Honglian, Huang, Yan, Zhao, Gangde, Chen, Lichang, Cai, Wei, Wang, Hui, Guo, Qing, Xie, Qing
Publicado 2021

Development and validation of a nomogram to predict failure of 14-day negative nucleic acid conversion in adults with non-severe COVID-19 during the Omicron surge: a retrospective...

por Gui, Honglian, Zhang, Zhenglan, Chen, Bin, Chen, Yaoxing, Wang, Yue, Long, Zhuo, Zhu, Chuanwu, Wang, Yinling, Cao, Zhujun, Xie, Qing
Publicado 2023

Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation

por Sun, Jingyuan, Li, Pei, Gui, Honglian, Rittié, Laure, Lombard, David B., Rietscher, Katrin, Magin, Thomas M., Xie, Qing, Liu, Li, Omary, M. Bishr
Publicado 2023

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores

por Huang, Yan, Chen, Lichang, Huang, Rui, Zhu, Chuanwu, Shang, Jia, Qian, Yunsong, Lian, Jianqi, Liu, Longgen, Jiang, Jianning, Liu, Chenghai, Gui, Honglian, Xie, Qing
Publicado 2022

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status

por Cao, Zhujun, Zhang, Chenxi, Zhao, Shuang, Sheng, Zike, Xiang, Xiaogang, Li, Ruokun, Qian, Zhuping, Wang, Yinling, Chen, Bin, Li, Ziqiang, Liu, Yuhan, An, Baoyan, Zhou, Huijuan, Cai, Wei, Wang, Hui, Gui, Honglian, Xin, Haiguang, Xie, Qing
Publicado 2022

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

por Cao, Zhujun, Gao, Weiyi, Bao, Hong, Feng, Haiyan, Mei, Shuya, Chen, Peizhan, Gao, Yueqiu, Cui, Zhilei, Zhang, Qin, Meng, Xianmin, Gui, Honglian, Wang, Weijing, Jiang, Yimei, Song, Zijia, Shi, Yiqing, Sun, Jing, Zhang, Yifei, Xie, Qing, Xu, Yiping, Ning, Guang, Gao, Yuan, Zhao, Ren
Publicado 2022